Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00490646
Status:
COMPLETED
Last Update Posted:
2016-03-10
First Post:
2007-06-21
Brief Title:
A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced andor Metastatic Breast Cancer
Sponsor:
R-Pharm
Organization:
R-Pharm
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-11
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-21
First Submit QC Date:
June 22 2007
Study First Post Date:
2007-06-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-07-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-02-09
Last Update Post Date:
2016-03-10
Last Update Post Date Type:
ESTIMATED